PL2844659T3 - Pochodne pirrolotriazynonowe - Google Patents

Pochodne pirrolotriazynonowe

Info

Publication number
PL2844659T3
PL2844659T3 PL13714859.9T PL13714859T PL2844659T3 PL 2844659 T3 PL2844659 T3 PL 2844659T3 PL 13714859 T PL13714859 T PL 13714859T PL 2844659 T3 PL2844659 T3 PL 2844659T3
Authority
PL
Poland
Prior art keywords
pyrrolotriazinone derivatives
pyrrolotriazinone
derivatives
Prior art date
Application number
PL13714859.9T
Other languages
English (en)
Inventor
Dieter Dorsch
Hans-Peter Buchstaller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2844659T3 publication Critical patent/PL2844659T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
PL13714859.9T 2012-05-04 2013-04-06 Pochodne pirrolotriazynonowe PL2844659T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12003445 2012-05-04

Publications (1)

Publication Number Publication Date
PL2844659T3 true PL2844659T3 (pl) 2016-11-30

Family

ID=48050660

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13714859.9T PL2844659T3 (pl) 2012-05-04 2013-04-06 Pochodne pirrolotriazynonowe

Country Status (21)

Country Link
US (1) US9174995B2 (pl)
EP (1) EP2844659B1 (pl)
JP (1) JP6097820B2 (pl)
KR (1) KR20150006873A (pl)
CN (1) CN104271580B (pl)
AR (1) AR090896A1 (pl)
AU (1) AU2013257018B2 (pl)
CA (1) CA2872334C (pl)
EA (1) EA027628B1 (pl)
ES (1) ES2587939T3 (pl)
HR (1) HRP20161033T1 (pl)
HU (1) HUE028325T2 (pl)
IL (1) IL235414A (pl)
MX (1) MX357502B (pl)
PL (1) PL2844659T3 (pl)
PT (1) PT2844659T (pl)
RS (1) RS55062B1 (pl)
SG (1) SG11201406997WA (pl)
SI (1) SI2844659T1 (pl)
WO (1) WO2013164061A1 (pl)
ZA (1) ZA201408876B (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2822656B1 (en) 2012-03-07 2016-10-19 Institute of Cancer Research: Royal Cancer Hospital (The) 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use
US9611223B2 (en) 2013-09-11 2017-04-04 Institute Of Cancer Research: Royal Cancer Hospital (The) 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use
CN105829317B (zh) * 2013-12-23 2019-03-29 默克专利股份公司 咪唑并吡嗪酮衍生物
UY36060A (es) 2014-04-02 2015-10-30 Bayer Pharma AG Compuestos de azol sustituidos con amida
AU2015245786B2 (en) * 2014-04-10 2018-03-15 Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. Analogues of 4H-pyrazolo[1,5-a]benzimidazole compound as PARP inhibitors
KR20160007347A (ko) * 2014-07-11 2016-01-20 에스티팜 주식회사 신규한 이미다조트리아지논 또는 이미다조피라지논 유도체, 및 이들의 용도
KR101775356B1 (ko) * 2015-07-06 2017-09-06 재단법인 아산사회복지재단 Parp 및 탄키라제 동시 저해제에 대한 감수성 결정 방법
CA3038280A1 (en) 2015-09-30 2017-04-06 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. - Generalverwaltung Heteroaryl derivatives as sepiapterin reductase inhibitors
WO2017055313A1 (en) 2015-10-01 2017-04-06 Bayer Pharma Aktiengesellschaft Amido-substituted azole compounds
WO2017055316A1 (en) 2015-10-01 2017-04-06 Bayer Pharma Aktiengesellschaft Amido-substituted azole compounds
ES2912648T3 (es) 2015-11-16 2022-05-26 Topadur Pharma Ag Derivados de 2-fenil-3,4-dihidropirrolo[2,1-f] [1,2,4]triazinona como inhibidores de la fosfodiesterasa y usos de los mismos
WO2017156350A1 (en) 2016-03-09 2017-09-14 K-Gen, Inc. Methods of cancer treatment
WO2018078009A1 (en) 2016-10-29 2018-05-03 Bayer Pharma Aktiengesellschaft Amido-substituted cyclohexane derivatives
WO2018078005A1 (en) 2016-10-29 2018-05-03 Bayer Pharma Aktiengesellschaft Amido-substituted azaspiro derivatives as tankyrase inhibitors
WO2018087126A1 (en) 2016-11-09 2018-05-17 Bayer Pharma Aktiengesellschaft Amido-substituted cyclohexane derivatives as inhibitors of tankyrase
CN109180702B (zh) * 2018-10-29 2021-11-30 四川大学 一种噻吩并嘧啶酮化合物及其用途
CN111961058B (zh) * 2020-08-03 2022-12-16 天津全和诚科技有限责任公司 4-氨基-吡咯并三嗪衍生物及其制备方法和用途
JP2025512935A (ja) 2022-04-08 2025-04-22 シャイ・セラピューティクス・エルエルシー がん、炎症性疾患、ras病、及び線維性疾患の処置のためのrasスーパーファミリータンパク質と相互作用する化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
JP4471404B2 (ja) 1996-02-13 2010-06-02 アストラゼネカ ユーケイ リミテッド Vegfインヒビターとしてのキナゾリン誘導体
ATE211134T1 (de) 1996-03-05 2002-01-15 4-anilinochinazolin derivate
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
NZ522074A (en) 2000-05-31 2004-06-25 Astrazeneca Ab Indole derivatives with vascular damaging activity
JP2004502766A (ja) 2000-07-07 2004-01-29 アンギオジェン・ファーマシューティカルズ・リミテッド 血管損傷剤としてのコルヒノール誘導体
CA2410562A1 (en) 2000-07-07 2002-01-31 Angiogene Pharmaceuticals Limited Colchinol derivatives as angiogenesis inhibitors
WO2004087056A2 (en) 2003-03-28 2004-10-14 Scios Inc. BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ
JP5046942B2 (ja) * 2004-09-30 2012-10-10 テイボテク・フアーマシユーチカルズ Hcv阻害性の二環式ピリミジン類
WO2008092861A1 (en) 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Bicyclic derivatives as ep4 agonists
SI2134691T1 (sl) * 2007-03-08 2012-06-29 Janssen Pharmaceutica Nv Derivati kvinolina kot PARP in TANK inhibitorji
CN101687874B (zh) * 2007-04-18 2013-01-30 百时美施贵宝公司 吡咯并三嗪激酶抑制剂

Also Published As

Publication number Publication date
JP6097820B2 (ja) 2017-03-15
CN104271580A (zh) 2015-01-07
EP2844659B1 (en) 2016-05-25
SI2844659T1 (sl) 2016-10-28
HUE028325T2 (en) 2016-12-28
MX2014013090A (es) 2014-12-08
CA2872334A1 (en) 2013-11-07
US20150133453A1 (en) 2015-05-14
EP2844659A1 (en) 2015-03-11
HRP20161033T1 (hr) 2016-10-21
MX357502B (es) 2018-07-12
SG11201406997WA (en) 2014-11-27
CA2872334C (en) 2020-06-30
CN104271580B (zh) 2017-02-22
AU2013257018B2 (en) 2017-02-16
EA201401212A1 (ru) 2015-08-31
RS55062B1 (sr) 2016-12-30
KR20150006873A (ko) 2015-01-19
ES2587939T3 (es) 2016-10-27
AU2013257018A1 (en) 2014-12-18
WO2013164061A1 (en) 2013-11-07
HK1205740A1 (en) 2015-12-24
AR090896A1 (es) 2014-12-17
EA027628B1 (ru) 2017-08-31
JP2015515961A (ja) 2015-06-04
IL235414A (en) 2017-11-30
ZA201408876B (en) 2017-06-28
US9174995B2 (en) 2015-11-03
PT2844659T (pt) 2016-08-31
WO2013164061A8 (en) 2014-11-06

Similar Documents

Publication Publication Date Title
ZA201409422B (en) Benzimidazole-proline derivatives
DK2830816T3 (en) Hidtil ukendt coatingkoncept
DK3327112T3 (en) Agse-deficient stamme
ZA201408876B (en) Pyrrolotriazinone derivatives
EP2935220A4 (en) PERI-carbinol
LT2838883T (lt) Nauji feniltetrahidroizochinolino dariniai
ZA201502175B (en) Oxazolidin-2-one-pyrimidine derivatives
IL236295A (en) The history of indanesulfamide
ZA201405108B (en) Substituted phenylazole derivative
PL2873660T3 (pl) Pochodna indolokarboksyamidu
SG11201404325VA (en) Pyrimidooxazocine derivatives as mtor - inhibitors
AU345893S (en) Treehouse
GB201202916D0 (en) E-Space
GB201202912D0 (en) Swingdoctor
GB201202655D0 (en) Ecogaz
GB201202648D0 (en) Xstyler
GB201202382D0 (en) Flexfix
GB201201767D0 (en) Pop-tops
GB201201668D0 (en) LOCnlatch
GB201201085D0 (en) Hit-a-pair
GB201202335D0 (en) Cabb
GB201200644D0 (en) Visualiser
GB201200467D0 (en) Coda251
GB201200226D0 (en) Kinibra
GB201200011D0 (en) Eggboiler